Options: Hide MedDRA Preferred Terms , display all 23 labels
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asthma | x | ||||||||||||||||||||||
| Bone cancer metastatic | x | x | x | x | |||||||||||||||||||
| Bone disorder | x | x | |||||||||||||||||||||
| Bone mass decreased | x | x | x | ||||||||||||||||||||
| Breast cancer | x | x | x | x | x | ||||||||||||||||||
| Dyspepsia | x | x | x | x | x | x | x | x | x | ||||||||||||||
| Fracture | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||||||
| Gastrointestinal disorder | x | x | x | x | x | x | x | x | x | x | x | x | |||||||||||
| Hypercalcaemia | x | x | x | ||||||||||||||||||||
| Metastasis | x | x | x | ||||||||||||||||||||
| Neoplasm | x | x | x | ||||||||||||||||||||
| Neoplasm malignant | x | x | x | x | x | x | |||||||||||||||||
| Osteoporosis | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||
| Osteoporosis postmenopausal | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||||||||
| Osteoporotic fracture | x | x | x | ||||||||||||||||||||
| Peptic ulcer | x | x | x | ||||||||||||||||||||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |